Cat. No. | Product name | CAS No. |
DCC2884 |
K00135
Novel potent and selective inhibitor of PIM kinases |
869650-21-5 |
DCC2885 |
K00518
Novel dual CLK1 and CLK3 inhibitor |
|
DCC2886 |
K103 Hydrochloride
Novel inhibitor of peptidoglycan synthesis targeting the lipid II precursor |
1071544-43-8 |
DCC2887 |
K-14585
Novel antagonist for proteinase-activated receptor 2 (PAR2) |
880546-17-8 |
DCC2888 |
K4610422
Novel norditerpenoid inhibitor of testosterone-5α-reductase |
|
DCC2889 |
K-8008
Novel inhibitor of the interaction of the N-terminally truncated RXR |
2276730-51-7 |
DCC2890 |
K-8012
Novel inhibitor of the interaction of the N-terminally truncated RXR |
1346513-17-4 |
DCC2891 |
Kaempulchraol P
Natural anti-inflammatory agent, inhibiting the NF-κB-mediated transactivation of a luciferase reporter gene, IL-6 production, and COX-2 expression |
|
DCC2892 |
Kaempulchraol Q
Natural anti-inflammatory agent, inhibiting the NF-κB-mediated transactivation of a luciferase reporter gene, IL-6 production, and COX-2 expression |
|
DCC2893 |
Kalb001
Novel mGlu4 ligand |
|
DCC2894 |
Kar425
Novel antimalarial agent, providing protection to malaria-infected mice |
1809050-49-4 |
DCC2895 |
Kasugamycin
Antibiotic, binding within the mRNA channel of the 30S subunit and inhibiting protein synthesis |
6980-18-3 |
DCC2896 |
Kb130015
Novel activator of hERG1 potassium channels, blocking native and recombinant hERG1 channels at high voltages, but activating them at low voltages |
147030-48-6 |
DCC2897 |
Kbh-a42
Novel histone deacetylase inhibitor |
798543-50-7 |
DCC2898 |
Kbjk557
Novel Plk1 PBD inhibitor, showing a remarkable in vitro anticancer effect by inducing Plk1 delocalization, mitotic arrest, and apoptosis in HeLa cells |
|
DCC2899 |
Kb-nb165-09
Selective inhibitor of Protein_kinase_D1>protein kinase D (PKD); Inhibitor of cell adhesion and HIV; Inhibitor of herpes simplex virus type 1 replication |
172832-10-9 |
DCC2900 |
Kbp-088
Novel highly potent dual amylin and calcitonin receptor agonist (DACRA), showing long-lasting improvement of food preference and body weight loss |
|
DCC2901 |
Kb-r7785
Novel ADAM12 and MMP inhibitor, ameliorating cardiac function in a transverse aortic constriction (TAC) model by inhibiting the proteolytic activation of HB-EGF signaling, exerting its antidiabetic effect by ameliorating insulin sensitivity through the in |
168158-16-5 |
DCC2902 |
Kc-11404
LTB4 inhibitor for the treatment of b-cell leukemias and lymphomas, potently inhibiting histamine, platelet activating factor,and 5-lipoxygenase |
148490-22-6 |
DCC2903 |
Kca075
Highly specific transglutaminase 2 (TG2) inhibitor |
|
DCC2904 |
Kca-1490
Dual PDE3/4 inhibitor |
909719-71-7 |
DCC2905 |
Kca2 Positive Modulator 2q
Novel potent and Subtype-Selective Positive Modulator of KCa2 Channels |